Form 4: Columbia Financial, Inc. Executive Jenifer White Walden Reports Acquisition of Common Stock

Sentiment:

SEC Form 4 Filing


EVP & CHRO of Columbia Financial, Inc., Jenifer White Walden, reports acquiring common stock through a stock-based deferral plan.

Summary

  • On July 26, 2024, Jenifer White Walden, EVP & CHRO of Columbia Financial, Inc., reported a transaction involving the acquisition of common stock.
  • The transaction involved the acquisition of 28.9663 shares of common stock at a price of $18.39 per share through a stock-based deferral plan.
  • Following the reported transaction, Walden directly owns 1,359 shares of common stock.
  • Walden also indirectly owns shares through various plans and awards, including the Stock-Based Deferral Plan (1,521.0677 shares), ESOP (982 shares), SERP (45 shares), SIM (14 shares), Stock Award (1,298 shares), Stock Award II (7,817 shares), and Stock Award III (7,597 shares).
  • Walden also holds stock options to purchase 5,540 shares at $20.54 (exercisable from October 31, 2023), 6,203 shares at $15.94 (exercisable from May 1, 2024), and 5,107 shares at $16.49 (exercisable from March 6, 2025).

Sentiment

Score: 6

Explanation: The sentiment is neutral as it reports a routine transaction. The acquisition of shares by an executive is generally viewed as a positive sign, but it's not a major event.

Positives

  • The acquisition of shares by an executive could be seen as a positive signal, indicating confidence in the company's future performance.

Industry Context

This filing is a routine disclosure of insider transactions, which are common in publicly traded companies. It provides transparency into the trading activities of company executives.

Stakeholder Impact

  • The transaction may have a minor positive impact on shareholder sentiment.

Key Dates

DateDescription
10/31/2023Commencement of vesting for stock options to buy 5,540 shares at $20.54
05/01/2024Commencement of vesting for stock options to buy 6,203 shares at $15.94
07/26/2024Date of transaction: Acquisition of 28.9663 shares of common stock at $18.39
07/30/2024Date of signature for the report
03/06/2025Commencement of vesting for stock options to buy 5,107 shares at $16.49
03/06/2034Expiration date for stock options to buy 5,107 shares at $16.49

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.